Regal Partners Ltd Has $24.37 Million Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Regal Partners Ltd boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 15.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 311,648 shares of the company’s stock after buying an additional 42,148 shares during the quarter. GE HealthCare Technologies makes up approximately 2.5% of Regal Partners Ltd’s portfolio, making the stock its 14th biggest position. Regal Partners Ltd owned 0.07% of GE HealthCare Technologies worth $24,365,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in GEHC. CoreFirst Bank & Trust acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $25,000. Runnymede Capital Advisors Inc. bought a new position in GE HealthCare Technologies during the fourth quarter worth $28,000. Bank of Jackson Hole Trust acquired a new stake in GE HealthCare Technologies in the fourth quarter worth $32,000. Flagship Wealth Advisors LLC bought a new stake in GE HealthCare Technologies in the fourth quarter valued at $34,000. Finally, OFI Invest Asset Management acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at about $34,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $68.09 on Wednesday. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market cap of $31.17 billion, a PE ratio of 15.73, a P/E/G ratio of 3.19 and a beta of 1.14. The business has a 50 day moving average of $75.62 and a 200-day moving average of $81.81. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.21%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio is 3.23%.

Analyst Ratings Changes

Several analysts have recently commented on the company. BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the company a “buy” rating in a research note on Monday, April 14th. Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Piper Sandler reduced their price objective on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $96.50.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.